Inactivation of Endothelial ZEB1 Impedes Tumor Progression and Sensitizes Tumors to Conventional Therapies

Journal of Clinical Investigation - United States
doi 10.1172/jci131507
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Circulating Endothelial Progenitors and Tumor Resistance to Vascular-Targeting Therapies

Cancer Discovery
Oncology
2012English

Zoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-Induced Programmed Cell Death

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

MYC Sensitizes Cancer Cells to Antimitotic Therapies

Cancer Discovery
Oncology
2015English

ATM Inhibition Sensitizes Tumors to High-Dose Irradiation

Cancer Research
Cancer ResearchOncology
2019English

X Chromosome Inactivation and Breast Cancer: Epigenetic Alteration in Tumor Initiation and Progression

2007English

Endothelial-Cell FAK Targeting Sensitizes Tumours to DNA-damaging Therapy

Nature
Multidisciplinary
2014English

Adeno-Associated Virus Sensitizes HeLa Cell Tumors to Gamma Rays.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1992English

Targeted Therapies to Improve Tumor Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2008English

ZEB1 Regulates Multiple Oncogenic Components Involved in Uveal Melanoma Progression

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy